Lipitor
Peripheral Vascular Disease
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Peripheral Vascular Disease cohort.
Same molecule, other indications
Lipitor is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →